kaiyun(Öйú)¹Ù·½ÍøÕ¾-¿ªÔÆÌåÓý¹Ù·½Èë¿Ú



¡¾Âö²¬Ò½Ò©¡¿MedBio|145224-94-8| MES monohydrate¼¼Êõ×ÊÁÏ

2021-03-10

2-(N-Âðßø)ÒÒ»ÇËáһˮÎï½á¹¹Ê½

MES monohydrateÖÐÎıðÃû£º2-(N-Âðßø)ÒÒ»ÇËᵥˮºÏÎï | һˮÂðßøÒÒ»ÇËá | ÂðßøÒÒ»ÇËá,һˮ | 2-(N-Âðßø)ÒÒ»ÇËáһˮºÏÎï

 

1¡¢2-(N-Âðßø)ÒÒ»ÇËáһˮÎïÎïÀí»¯Ñ§ÐÔÖÊ£º

ÃÜ¶È 1.349 g/cm3
ÈÛµã >300 ¡ãC(lit.)
·Ö×Óʽ C6H15NO5S
·Ö×ÓÁ¿ 213.252
¾«È·ÖÊÁ¿ 213.067093
PSA 84.45000
LogP 0.16080
Íâ¹ÛÐÔ×´ °×É«½á¾§·ÛÄ©
´¢´æÌõ¼þ

±£´æ·½·¨£ºÃܱգ¬ÒõÁ¹£¬Í¨·ç¸ÉÔï´¦

Îȶ¨ÐÔ

µÍÅÝÐÍ·ÇÀë×Ó±íÃæ»îÐÔ¼Á£¬¾ßÓзÇÀë×Ó±íÃæ»îÐÔ¼ÁµÄÒ»ÇÐÐÔÖÊ¡£×ǵã¸ù¾Ý£Ò£²µÄ²»Í¬ÓÐËù²î±ð£¬¿ÉÔÚ25¡«55¡æ¡£ÅÝĭΪ¾ÛÑõÒÒÏ©ÐÍ·ÇÀë×Ó±íÃæ»îÐÔ¼ÁµÄ1/3¡«1/5¡£¾ßÓÐÁ¼ºÃµÄÈ黯¡¢·ÖÉ¢ºÍ¾»Ï´ÐÔÄÜ£¬ÄÍӲˮÐԺã¬ÔÚËá¡¢¼î¡¢Ï¡Ñõ»¯¼Á´æÔÚϽÏÒ»°ã·ÇÀë×Ó±íÃæ»îÐÔ¼ÁÎȶ¨¡£¿ÉÈÜÓÚ±ûͪ¡¢ËÄÂÈ»¯Ì¼¡¢¶þ¼×±½ºÍË®¡£ÎÞ¶¾£¬ÉúÎï¿É½µ½â¡£

Ë®ÈܽâÐÔ H2O: 0.5 M at 20 ¡ãC, clear
·Ö×ӽṹ

1¡¢Ä¦¶ûÕÛÉäÂÊ£ºÎÞ¿ÉÓõÄ

2¡¢Ä¦¶ûÌå»ý£¨cm3/mol£©£ºÎÞ¿ÉÓõÄ

3¡¢µÈÕűÈÈÝ£¨90.2K£©£ºÎÞ¿ÉÓõÄ

4¡¢±íÃæÕÅÁ¦£¨dyne/cm£©£ºÎÞ¿ÉÓõÄ

5¡¢½éµç³£Êý£ºÎÞ¿ÉÓõÄ

6¡¢¼«»¯ÂÊ£¨10-24cm3£©£ºÎÞ¿ÉÓõÄ

7¡¢µ¥Ò»Í¬Î»ËØÖÊÁ¿£º213.067093 Da

8¡¢±ê³ÆÖÊÁ¿£º213 Da

9¡¢Æ½¾ùÖÊÁ¿£º213.252 Da

¼ÆË㻯ѧ

1.ÊèË®²ÎÊý¼ÆËã²Î¿¼Öµ£¨XlogP£©:ÎÞ

2.Çâ¼ü¹©ÌåÊýÁ¿:2

3.Çâ¼üÊÜÌåÊýÁ¿:6

4.¿ÉÐýת»¯Ñ§¼üÊýÁ¿:3

5.»¥±äÒì¹¹ÌåÊýÁ¿:ÎÞ

6.ÍØÆË·Ö×Ó¼«ÐÔ±íÃæ»ý76.2

7.ÖØÔ­×ÓÊýÁ¿:13

8.±íÃæµçºÉ:0

9.¸´ÔÓ¶È:214

10.Í¬Î»ËØÔ­×ÓÊýÁ¿:0

11.È·¶¨Ô­×ÓÁ¢¹¹ÖÐÐÄÊýÁ¿:0

12.²»È·¶¨Ô­×ÓÁ¢¹¹ÖÐÐÄÊýÁ¿:0

13.È·¶¨»¯Ñ§¼üÁ¢¹¹ÖÐÐÄÊýÁ¿:0

14.²»È·¶¨»¯Ñ§¼üÁ¢¹¹ÖÐÐÄÊýÁ¿:0

15.¹²¼Û¼üµ¥ÔªÊýÁ¿:2

 

2¡¢2-(N-Âðßø)ÒÒ»ÇËáһˮÎïÉú̬ѧÊý¾Ý£º

ÆäËüÓк¦×÷ÓãºÍ¨³£¶ÔË®ÉÔ΢Σº¦µÄ£¬ÈôÎÞÕþ¸®Ðí¿É£¬Î𽫲ÄÁÏÅÅÈëÖÜΧ»·¾³¡£

3¡¢2-(N-Âðßø)ÒÒ»ÇËáһˮÎïÐÔÖÊÓëÎȶ¨ÐÔ£º

µÍÅÝÐÍ·ÇÀë×Ó±íÃæ»îÐÔ¼Á£¬¾ßÓзÇÀë×Ó±íÃæ»îÐÔ¼ÁµÄÒ»ÇÐÐÔÖÊ¡£×ǵã¸ù¾Ý£Ò£²µÄ²»Í¬ÓÐËù²î±ð£¬¿ÉÔÚ25¡«55¡æ¡£ÅÝĭΪ¾ÛÑõÒÒÏ©ÐÍ·ÇÀë×Ó±íÃæ»îÐÔ¼ÁµÄ1/3¡«1/5¡£¾ßÓÐÁ¼ºÃµÄÈ黯¡¢·ÖÉ¢ºÍ¾»Ï´ÐÔÄÜ£¬ÄÍӲˮÐԺã¬ÔÚËá¡¢¼î¡¢Ï¡Ñõ»¯¼Á´æÔÚϽÏÒ»°ã·ÇÀë×Ó±íÃæ»îÐÔ¼ÁÎȶ¨¡£¿ÉÈÜÓÚ±ûͪ¡¢ËÄÂÈ»¯Ì¼¡¢¶þ¼×±½ºÍË®¡£ÎÞ¶¾£¬ÉúÎï¿É½µ½â¡£

4¡¢2-(N-Âðßø)ÒÒ»ÇËáһˮÎïÖü´æ·½·¨£º

Ãܱգ¬ÒõÁ¹£¬Í¨·ç¸ÉÔï´¦

5¡¢2-(N-Âðßø)ÒÒ»ÇËáһˮÎïÎÄÏ×£º

A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.
Oncotarget 6 , 39276-91, (2015)

Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.
Biochem. Pharmacol. 90(4) , 367-78, (2014)

Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation.
Mol. Pharm. 11(7) , 2334-45, (2014)

6¡¢2-(N-Âðßø)ÒÒ»ÇËáһˮÎïÓ¢ÎıðÃû£º

2-(4-Morpholinyl)ethanesulfonic acid hydrate (1:1)
2-(N-Morpholino)ethanesulfonic acid,4-Morpholineethanesulfonic acid monohydrate
4-Morpholineethanesulfonic acid, hydrate (1:1)
2-Morpholinoethanesulfonic acid Monohydrate
2-(4-morpholinyl)ethanesulfonic acid hydrate
4-Morpholineethanesulfonic acid monohydrate
MFCD00149409
2-(Morpholin-4-yl)ethanesulfonic acid hydrate (1:1)
MES monohydrate
MES hydrate
EINECS 224-632-3
2-Morpholinoethanesulfonic acid hydrate
»õºÅ ²úÆ·Ãû³Æ Æ·ÅÆ ¹æ¸ñÐͺаü×° Ŀ¼¼Û ÊýÁ¿ ¹ºÎï³µ
MED80035 MES monohydrate ,145224-94-8 MedBio ¡Ý98% 5g ?31.00
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿